Clinical Trial Update: Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting Zemaira (alpha-1 proteinase inhibitor) results in subjects with emphysema due to alpha-1 antitrypsin deficiency; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Emphysema

Drugs mentioned

• Zemaira (human alpha-1 proteinase inhibitor)

Snippet

Sponsor: CSL Behring | Conditions: Alpha1-proteinase Inhibitor Deficiency, Emphysema | Phase 4 | Status: COMPLETED | Results posted: 2015-01-19